A 21‐year‐old man presented to us with involuntary jerking movements of his hands and head that started at the age of 13. In the early years, the movements would come in intermittent spells, and sometimes his whole body would tremble when anxious, concentrating on an activity, or riding his scooter. Initially mild, the movements had progressed to moderate severity over the last few years. While he could still do all activities unhindered, and symptoms were mostly an inconvenience, they were increasingly causing him embarassment. Family history was negative, and he had never used alcohol. On examination, myoclonic jerking of the neck and both hands was present at rest and action (Video 1, Segment 1). There was no involvement of face, trunk, or lower limbs, and brain MRI, metabolic testing, EEG, and SSEP were normal. A clinical diagnosis of myoclonus‐dystonia (M‐D) syndrome was made.
Targeted gene sequencing for a dystonia gene panel revealed a heterozygous missense variation in exon 2 of ADCY5 gene (chr3:123071310C > T; Depth: 261x), resulting in an amino acid substitution of glutamine for arginine at codon 418 (p.Arg418Gln). This variant (p.R418Q) and a different amino acid substitution affecting the same codon, have previously been reported in patients with ADCY5‐related dyskinesia.1
Two years later, perioral action‐induced facial myoclonus was noted (Video 1, Segment 2). Propranolol and clonazepam provided moderate symptomatic relief from myoclonus.
Discussion
ADCY5‐related disease causes a young‐onset mixed hyperkinetic disorder with chorea/ballism, dystonia, myoclonus (characteristically with a facial predilection), or tremor.1, 2 Episodic worsening, triggered by anxiety, stress, or inactivity, and characteristically, periods before or after sleep (with or without ballistic bouts) may be present.1, 2
Our patient fulfilled criteria for M‐D syndrome,3, 4 including the presence of primarily myoclonic jerks and milder dystonia confined to the upper body, onset before age 18, initially intermittent symptoms, no additional neurological features, normal cognition, and normal neuroimaging. However, the lightning jerks in the cervical region, classic for true SGCE‐related M‐D, were absent. In patients with M‐D syndrome, an SGCE mutation is found in only 30 to 40% of patients,4 and the genetic basis of other patients is largely unknown.
On reviewing the phenotypic presentations of previously published ADCY5 cases,1, 2 ,other we could only find two instances where M‐D was considered to be a presenting feature by the authors. One, in 1 of 7 cases reported by Chang,1 and the other, in some members of a recently reported, separate family.5 However, in both these reports, additional features that are clearly atypical for M‐D were present, including chorea,1 leg and orolingual dystonia, speech impairment, facial jerks, and ataxia.5
Interestingly, a number of clinical similarities can be noted to exist between the M‐D syndrome and ADCY5, including a young‐onset presentation, craniocervical region myoclonus and/or dystonia, and a benign course. However, additional features in ADCY5 can include facial myoclonus, oculomotor apraxia, sleep exacerbations, axial hypotonia/developmental delay in children, and paroxysmal episodes (the latter could be an early clue to ADCY5 in our patient)—all of which are notably absent in M‐D.
ADCY5 mutations in residues 418 (as in our patient) and 726 are particularly functionally impactful for pathogenesis,5 causing a gain‐of‐function change in ADCY5 protein, leading to altered dopaminergic striatal signaling.6
In summary, we report M‐D as a presentation of ADCY5. This case is also the first reported Indian occurrence of any adult‐onset movement disorder due to ADCY5, and it underscores the importance of considering ADCY5 in adult Indian patients with hyperkinetic movement disorders.
Author Roles
1. Research Project: A. Conception, B. Clinical Examinations, C. Literature Review, D. video Recording and Editing, E. Genetic Testing; 2. Manuscript: A. Writing of the First Draft B. Review and Critique
P.A.A.: 1A, 1B, 1C, 1D, 2A, 2B
V.L.R.: 1C, 1E, 2B
Disclosures
Ethical Compliance Statement: The authors confirm that the approval of an institutional review board was not required for this work. The patient has given written and informed consent for online publication of his videos. We also confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.
Funding Sources and Conflicts of Interest: The authors report no sources of funding and no conflicts of interest.
Financial Disclosures for the previous 12 months: The authors report no sources of funding and no conflicts of interest.
Supporting information
Acknowledgments
We thank Dr. Dinesh Singh, Mumbai for the patient referral, and the patient and his family for their cooperation.
Relevant disclosures and conflicts of interest are listed at the end of this article.
References
- 1. Chang FC, Westenberger A, Dale RC, et al Phenotypic insights into ADCY5‐associated disease. Mov Disord 2016;31(7):1033–1040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Chen DH, Méneret A, Friedman, JR , et al. ADCY5‐related dyskinesia: Broader spectrum and genotype‐phenotype correlations. Neurology 2015;85(23):2026–2035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Roze E, Lang AE, Vidailhet M. Myoclonus‐dystonia: classification, phenomenology, pathogenesis, and treatment. Curr Opin Neurol 2018;31(4):484–490. [DOI] [PubMed] [Google Scholar]
- 4. Raymond D, Ozelius L. Myoclonus‐Dystonia In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, eds. GeneReviews [Internet] 1993. ‐2018. Seattle, WA: University of Washington, Seattle; 1993‐2018; 2003 [updated 2012]. https://www.ncbi.nlm.nih.gov/books/NBK1414. Accessed December 21 2018. [Google Scholar]
- 5. Douglas AG, Andreoletti G, Talbot K, et al. ADCY5‐related dyskinesia presenting as familial myoclonus‐dystonia. Neurogenetics 2017;18(2):111–117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Chen YZ, Friedman JR, Chen DH, et al. Gain‐of‐function ADCY5 mutations in familial dyskinesia with facial myokymia. Ann Neurol 2014;75(4):542–549. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.